Literature DB >> 6329963

New perspectives in myringoplasty.

F E Kohn, J Feijen, L Feenstra.   

Abstract

Until 1950 the treatment of a perforated eardrum consisted of covering the drum permanently with artificial material. Since then a surgical technique to establish a functional reconstruction of the eardrum was developed (myringoplasty). A survey of the biological grafting materials used in this technique is given. Biodegradable and non-degradable synthetic materials may prove to be a valuable supplement of the existing biological grafting materials. Artificial eardrums made from several biodegradable poly(alpha-hydroxy acids) and poly(alpha-amino acids) and made from a number of microporous poly(tetrafluorethylene) membranes and from a microporous bisphenol-A poly(carbonate) membrane were implanted into the ears of rats and dogs and as a reference subcutaneously. The implants were histologically examined for periods up to one year. From the biodegradable polymers studied poly(beta-benzyl-L-aspartate-co-L-leucine) 50/50 evoked the least tissue reaction and the newly formed eardrums were the best in terms of thickness and overall integrity. The formation of a reinforced eardrum may be accomplished by the support of an inert, very thin, highly porous poly(tetrafluoroethylene membrane) preferably implanted as a composite graft with a biodegradable polymer.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329963

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  2 in total

1.  Design, fabrication, and in vitro testing of novel three-dimensionally printed tympanic membrane grafts.

Authors:  Elliott D Kozin; Nicole L Black; Jeffrey T Cheng; Max J Cotler; Michael J McKenna; Daniel J Lee; Jennifer A Lewis; John J Rosowski; Aaron K Remenschneider
Journal:  Hear Res       Date:  2016-03-16       Impact factor: 3.208

2.  Bilayer Graft for Incisionless In-Office Endoscopic Repair of Tympanic Membrane Perforations: A Pilot Study.

Authors:  Elliott D Kozin; Daniel J Lee; Aaron K Remenschneider
Journal:  OTO Open       Date:  2019-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.